Interindividual Differences in Chronopharmacologic Effects of Drugs: A Background for Individualization of Chronotherapy

References

• Chronopharmacology, B Lemmer. Marcel Dekker, New York 1990
   Google Scholar
• Reinberg A, Labrecque G, Smolensky M. Chronobiologie et Chronothérapeutique. Paris: Flammarion Médecine-Sciences. English translation American Pharmaceutical Assoc. 1991, in press
   Google Scholar
• Konopka RJ, Benzer R. Clock mutants of Drosophila melanogaster. Proc Nail Acad Sci USA 1971; 58: 2112–6
   Web of Science ®Google Scholar
• Feldman J. Clock mutants in Neurospora. Ann Rev Plant Physiol 1982; 33: 583–608
   Google Scholar
• Ashkenazi IE, Cohen-Kitay Y, Carlebach R. Chronotoxicity and phenotypic variability. Ann Rev Chronopharmacol 1990; 7: 241–4
   Google Scholar
• Lévi F, Boughattas NA, Blazsek I. Comparative murine chronotoxicity of anti-cancer agents and related mechanism. Ann Rev Chronopharmacol 1986; 4: 283–91
   Google Scholar
• Possidente B, Exner R. Gene-dependent effect of lithium on circadian rhythms in mice. Ann Rev Chronopharmacol 1986; 3: 25–7
   Google Scholar
• Ollagnier M, Gay JP, Cherrah Y, Decousus H, Reinberg A. Is acetylator phenotype distribution dependent of circadian rhythms. Ann Rev Chronopharmacol 1988; 5: 257–8
   Google Scholar
• Ashkenazi IE, Reinberg A, Bicakova-Rocher A, Aharon T. The genetic backgound of individual variations of circadian-rhythm periods in healthy human adults. Am J Hum Genet 1993; 52: 1250–9
   PubMed Web of Science ®Google Scholar
• Minors D, Waterhouse JM. Aspects of chronopharmacokinetics and chronergy of ethanol in healthy men. Chronohiologia 1980; 7: 465–80
   PubMedGoogle Scholar
• Bruguerolle B, Bouvenot G, Bartolin R. Temporal and sex-related variations in lorazepam kinetics. Ann Rev Chronopharmacol 1984; 1: 21–4
   Google Scholar
• Jonkman J HG, Reinberg A, Oosterhuis B, et al. Dosing time and sex-related differences in the pharma-cokinetics of cefodizime. Chronobiologia 1988; 15: 89–102
   Google Scholar
• Reinberg A, Lévi F, Smolensky M, . Chronokinetics. Comparative medical chemistry, CJ Drayton, et al. Pergamon Press, Oxford 1990; Vol. 5: 279–95, Chapter 21
   Google Scholar
• Bruguerolle B, Barbeau G, Bellanger P. Chronokinetics of indomethacin in elderly subjects. Ann Rev Chronopharmacolol 1986; 3: 425–8
   Google Scholar
• Clench J, Reinberg A, Dziewanowska Z, Ghata J, Smolensky M. Circadian changes in the bioavailabil-ity and effects of indomethacin in healthy subjects. Eur J Clin Pharmacol 1981; 20: 359–69
   PubMed Web of Science ®Google Scholar
• Haus E, Nicolau GY, Lakatua D. Reference values for chronopharmacology. Ann Rev Chronopharmacol 1988; 4: 333–424
   Google Scholar
• Touitou Y, Touitou C, Bogdan A, et al. Differences in seasonal and circadian variations in total plasma proteins and blood volume as reflected by hemoglobin, hematocrit and erythrocyte counts. A transverse study in young and elderly subjects. Clin Chem 1986; 32: 801–4
   PubMed Web of Science ®Google Scholar
• Halberg F, Reinberg A. Rythmes circadiens et rythmes de basses fréquences en physiologie humaine. J Physiol (Paris) 1967; 59: 117–200
   PubMedGoogle Scholar
• Bruguerolle B, Lévi F, Touitou Y, et al. Alteration of the physiologic circadian time structure of six plasma proteins in patients with advanced cancer. Ann Rev Chronopharmacol 1986; 3: 207–10
   Google Scholar
• Touitou Y, Lévi F, Bogdan A, Bruguerolle B. Abnormal patterns of plasma cortisol in breast cancer patients. Ann Rev Chronopharmacol 1990; 7: 245–8
   Google Scholar
• Bailleul F, Lévi F, Reinberg A, et al. Interindividual differences in the circadian hematologic time structure of cancer patients. Chronobiol Int 1986; 3: 47–54
   PubMedGoogle Scholar
• Benavides-Orgaz M. Cancer avancé de l'ovaire: approche chronobiologique comme nouvelle stratégie dutraitement etde la surveillance clinique et biologique [Thesis]. Universitedé Paris XI, Paris 1991
   Google Scholar
• Lévi F, Adam R, Soussan A, et al. Ambulatory 5-day chronotherapy of colorectal or pancreatic cancer with continuous venous infusion of 5-fluorocuracil at circadian-modulated rate. Ann Rev Chronopharmacol 1988; 5: 419–22
   Google Scholar
• Simpson HW, Bellamy N, Bohlen J, Halberg F. Double blind trial of a possible chronobiotic: quiadon. Inter J Chronobiol 1973; 1: 287–311
   PubMedGoogle Scholar
• Reinberg A, Smolensky M, Labrecque G. The hunting of the wonder pill for resetting all biological clocks. Ann Rev Chronopharmacol 1988; 4: 171–200
   Google Scholar
• Reinberg A. Chronopharmacology of corticosteroids and ACTH. Chronopharmacology, B Lemmer. Marcel Dekker, New York 1990; 137–67
   Google Scholar
• Radialowski FM, Bousquet WF. Daily rhythmic variation in hepatic drug metabolism in that and mouse. J Pharmacol Exp Ther 1969; 163: 229–38
   Google Scholar
• Labrecque G, Bellenger PM. Chronopharmacology of the inflammatory process. Ann Rev Chronopharmacol 1985; 2: 291–325
   Google Scholar
• Reinberg A, Ghata J, Halberg F, et al. Distribution temporelle du traitement de l'insuffisance cortico-surrénalienne. Essai chronothérapeutique. Ann Endocrinol (Paris) 1971; 32: 566–73
   Google Scholar
• Reinberg A, Ghata J, Abulker C, Dupont J. Treatment schedules modify circadian timing in human adrenocorticel insufficiency. Chronobiologv, LE Scheving, F Halberg, JE Pauly. Igaku Shoin, Tokyo 1974; 168–73
   Google Scholar
• Reinberg A, Ghata J, Abulker C. Chronic (5 to 24 years) chronocorticotherapy in adrenocotical insufficiency. Comparison between two treatment schedules. Chrono-pharmacoiogy, A Reinberg, F Halberg. Pergamon Press, Oxford 1979; 77–84
   Google Scholar
• Carlebach R, Ravid M, Peleg L, Ashkenazi IE, Cohen-Kitay Y. Chronotoxicity of anti-cancer drugs: II: recovery patterns. Ann Rev Chronopharmacol 1988; 5: 357–8
   Google Scholar
• Peleg L, Ashkenazi IE, Carlebach R, Chaitchik S. Time-dependent toxicity of drugs used in cancer chemotherapy: separate and combined administration. Int J Cancer 1989; 44: 274–5
   Google Scholar
• Boughattas NA. Rythmes de la pharmacocinétique et de la pharmacodynamie de trois agents anti-cancéreux (cisplatin, oxaloplatine et carboplatine) chez le souris: approche de leurs régulations [Thesis]. Université de Paris II, Paris 1989
   Google Scholar
• Schaison G, George M, Lestrat N, Reinberg A, Beaulieu EE. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women. J Clin Endocrinol Metab 1985; 61: 484–9
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Barnes PJ, Reinberg A. Chronobiology of asthma. 1. Day-night differences in bronchial patency and dyspnea and circadian rhythm dependencies. J Asthma 1986; 23: 321–43
   PubMed Web of Science ®Google Scholar
• Sothern RB, Halberg F, Hrushesky W JM. Persistence of doxorubicin susceptibility rhythm for mice in constant light: circadian stage vs. time of day. Ann Rev Chronopharmacol 1988; 5: 385–8
   Google Scholar
• Soulban G, Smolensky MH, Yonovitz A. Gentamicin-induced chronotoxicity: use of body temperature as a circadian marker rhythm. Chronobiol Int 1990; 7: 393–402
   PubMed Web of Science ®Google Scholar
• Touitou Y, Motohashi Y, Pati A, Lévi F, Reinberg A. Comparison of cortisol circadian rhythms documented in samples of saliva, capillary (finger tips) and venous blood from healthy subjects. Ann Rev Chronopharmacol 1986; 3: 297–9
   Google Scholar
• Dawes C. Rhythms in salivary flow rate and composition. Int J Chronobiol 1974; 2: 253–9
   PubMedGoogle Scholar
• Reinberg A, Pouchet F, Ruff F, Gervais P, Smolensky MH. Comparison of once-daily evening vs. morning sustained-release theophylline dosing for nocturnal asthma. Chronobiol Int 1987; 4: 409–19
   PubMed Web of Science ®Google Scholar
• Simpson H, Griffith K. The diagnosis of breast pre-cancer by the chronobra: I and II. Chronobiol Int 1989; 6: 355–93
   PubMedGoogle Scholar
• Gupta B, Deka AC. Application of chronobiology to radiotherapy of tumor oral cavity. Chronobiologv 1975; 2(suppl 1)125
   Google Scholar
• Touitou Y, Hrushesky W JM, Focan C, Auzeby A, Bogdan A. Plasma carcino embryonic antigen (CEA) rhythm in patients with ovarian cancer: effect of chemotherapy. Ann Rev Chronopharmacol 1984; 1: 141–3
   Google Scholar
• Hallek M, Emmerich B, Reichl A, Schick HD, Senekowischt R, Reinberg A. Observation of circadian rhythm of serum thymidine kinase levels in control and tumor patient. Ann Rev Chronopharmacol 1988; 5: 361–4
   Google Scholar
• Focan A. Chronobiologie et marqueurs biochimiques de cancer. Pathol Biol (Paris) 1987; 35: 951–9
   Google Scholar
• Szafarczyk A, Ixart G, Alonso G, Nouguier J, Assenmacher I. Neural control of circadian rhythm in plasma circosterone and motor activity. J Physiol (Paris) 1981; 77: 969–76
   PubMedGoogle Scholar
• Guillement J, Guillement S, Reinberg A. Circadian variation of adrenocortical cyclic nucleotides (AMPc and GMPc) in hypophystomized rats. Experientia 1986; 36: 367–9
   Google Scholar
• Biological rhythms and their central mechanism, M Suda, O Hayaishi, H Nakagawa. Elsevier/North Holland Biomedical Press, Amsterdam 1979
   Google Scholar
• English J, Aherne G, Arendt J. Modulation of the circadian rhythm in methotrexate toxicology in the rat by melatonin and photoperiod. Ann Rev Chronopharmacol 1988; 5: 359
   Google Scholar
• Edgar DM, Martin CE, Dement WC. Activity feed back to the mammalian circadian pace maker. Influence on observed measures of rhythm period length. J Biol Rhythms 1991; 6: 185–99
   PubMed Web of Science ®Google Scholar